Growth Plate Chondrocyte Maturation Is Regulated by Basal Intracellular Calcium

2002 ◽  
Vol 277 (2) ◽  
pp. 233
Author(s):  
Michael J Zuscik ◽  
Mary D'Souza ◽  
Karlene K Gunter ◽  
Thomas E Gunter ◽  
Regis J O'Keefe ◽  
...  
2002 ◽  
Vol 276 (2) ◽  
pp. 310-319 ◽  
Author(s):  
Michael J. Zuscik ◽  
Mary D'Souza ◽  
Karlene K. Gunter ◽  
Thomas E. Gunter ◽  
Regis J. O'Keefe ◽  
...  

2006 ◽  
Vol 0 (0) ◽  
pp. 060913044658051 ◽  
Author(s):  
Cristina C. Teixeira ◽  
Yelena Nemelivsky ◽  
Claudia Karkia ◽  
Racquel Z. Legeros

2006 ◽  
Vol 12 (8) ◽  
pp. 2283-2289 ◽  
Author(s):  
Cristina C. Teixeira ◽  
Yelena Nemelivsky ◽  
Claudia Karkia ◽  
Racquel Z. Legeros

1998 ◽  
Vol 111 (6) ◽  
pp. 803-813
Author(s):  
P.R. Romano ◽  
J. Wang ◽  
R.J. O'Keefe ◽  
J.E. Puzas ◽  
R.N. Rosier ◽  
...  

We have previously identified and partially cloned Band 17, a gene expressed in growth plate chondrocytes transiting from proliferation to hypertrophy. We now rename this gene HiPER1, Histidine Phosphatase of the Endoplasmic Reticulum-1, based on the results reported here. HiPER1 encodes two proteins of 318 (HiPER1(318)) and 449 (HiPER1(449)) amino acids, which are 20–21% identical to a group of yeast acid phosphatases that are in the histidine phosphatase family. HiPER1(449) is significantly more abundant than HiPER1(318), correlating with the abundance of the alternatively spliced messages encoding HiPER449 and HiPER318. Anti-HiPER1 antibodies detect two proteins of 53 and 55 kDa in growth plate chondrocytes that are absent in articular chondrocytes. We confirm that the 53 and 55 kDa proteins are HiPER1(449) by heterologous expression of the HiPER1(449) coding sequence in chick embryo fibroblasts. The 53 and 55 kDa proteins are glycosylated forms of HiPER1(449), as N-glycosidase F digestion reduces these proteins to 48 kDa, the predicted size of HiPER1(449) without the N-terminal signal sequence. Immunocytochemistry demonstrates that HiPER1(449) is found in chondrocytes maturing from proliferation to hypertrophy, but is not detectable in resting zone, deep hypertrophic zone or articular chondrocytes, a distribution that is consistent with the message distribution. HiPER1(449) was predicted to localize to the lumen of endoplasmic reticulum by an N-terminal signal sequence and by the C-terminal sequence Ala-Asp-Glu-Leu, which closely matches the consensus signal for ER retention, Lys-Asp-Glu-Leu. We confirm this prediction by demonstrating colocalization of HiPER1(449) with the ER protein HSP47 using dual-label immunofluorescence. PTHrP, a peptide that prevents hypertrophy in chondrocytes, suppressed HiPER1 and HiPER1(449) expression in vitro, an observation that further supports a role for HiPER1 in chondrocyte maturation. The yeast phosphatase homology, localization to the endoplasmic reticulum and pattern of expression suggest that HiPER1 represents a previously unrecognized intracellular pathway, involved in differentiation of chondrocytes.


1985 ◽  
Vol 67 (6) ◽  
pp. 942-955 ◽  
Author(s):  
J A Buckwalter ◽  
D Mower ◽  
J Schafer ◽  
R Ungar ◽  
B Ginsberg ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Vivi F. H. Jensen ◽  
Anne-Marie Mølck ◽  
Ingrid B. Bøgh ◽  
Jette Nowak ◽  
Birgitte M. Viuff ◽  
...  

AbstractMaternal hypoglycaemia throughout gestation until gestation day (GD)20 delays foetal growth and skeletal development. While partially prevented by return to normoglycaemia after completed organogenesis (GD17), underlying mechanisms are not fully understood. Here, we investigated the pathogenesis of these changes and significance of maternal hypoglycaemia extending beyond organogenesis in non-diabetic rats. Pregnant rats received insulin-infusion until GD20 or GD17, with sacrifice on GD20. Hypoglycaemia throughout gestation increased maternal corticosterone levels, which correlated with foetal levels. Growth plates displayed central histopathologic changes comprising disrupted cellular organisation, hypertrophic chondrocytes, and decreased cellular density; expression of pro-angiogenic factors, HIF-1α and VEGF-A increased in surrounding areas. Disproportionately decreased growth plate zone volumes and lower expression of the structural protein MATN-3 were seen, while bone ossification parameters were normal. Ending maternal/foetal hypoglycaemia on GD17 reduced incidence and severity of histopathologic changes and with normal growth plate volume. Compromised foetal skeletal development following maternal hypoglycaemia throughout gestation is hypothesised to result from corticosterone-induced hypoxia in growth plates, where hypoxia disrupts chondrocyte maturation and growth plate structure and volume, decreasing long bone growth. Maternal/foetal hypoglycaemia lasting only until GD17 attenuated these changes, suggesting a pivotal role of glucose in growth plate development.


Sign in / Sign up

Export Citation Format

Share Document